CYPHERPUNK TECHNOLOGIES INC.

Cypherpunk Technologies Inc. held its 2026 Annual Meeting of Stockholders on June 18, 2026. Shareholders elected Will McEvoy and Nissim Mashiach as Class III directors to serve until the 2029 annual meeting. Additionally, stockholders approved, on an advisory basis, the executive compensation of the company's named executive officers and ratified the appointment of EisnerAmper LLP as the independent registered public accounting firm for fiscal year 2026.

Cypherpunk Technologies Inc. announced that it has regained compliance with Nasdaq's minimum bid price requirement. The company received a letter from Nasdaq on May 21, 2026, confirming compliance with Listing Rule 5550(a)(2), which had previously been violated due to the stock trading below $1.00 per share for 30 consecutive business days. This closes the matter with Nasdaq.

Cypherpunk Technologies reported a net loss of $77.2 million for Q1 2026, significantly wider than the $15.4 million loss in Q1 2025, primarily due to a $77.6 million unrealized loss on its ZEC treasury holdings as the ZEC price declined. Despite this, the company increased its Zcash holdings to 314,185.70 ZEC and made a $5 million investment in Zcash Open Development Labs. Its subsidiary, Leap Therapeutics, received FDA Fast Track designation for sirexatamab and presented positive Phase 2 DeFianCe study results for colorectal cancer.

Cypherpunk Technologies Inc. reported a net loss of $(77.17) million for the first quarter of 2026, significantly wider than the $(15.44) million loss in Q1 2025, primarily due to a $(77.56) million unrealized loss on the fair value of its digital asset derivative. The company's digital assets receivable decreased to $73.85 million and cash and cash equivalents fell to $6.69 million as of March 31, 2026. This comes after the company's strategic shift in late 2025 to a digital asset treasury strategy focused on Zcash, alongside winding down most of its biotechnology research and development operations, which led to a substantial reduction in R&D expenses.

Cypherpunk Technologies Inc. announced its 2026 Annual Meeting of Stockholders will be held virtually on June 18, 2026, at 11:00 a.m. Eastern Time. Stockholders of record as of April 29, 2026, are eligible to vote on proposals including the election of two Class III directors, an advisory vote on executive compensation, and the ratification of EisnerAmper LLP as independent auditors. Joseph Loscalzo and Christopher Mirabelli will step down from the Board, and James Cavanaugh and Richard Schilsky also intend to resign, reducing the board size.

CYPHERPUNK TECHNOLOGIES INC. (CYPH) announced its 2026 Annual Meeting of Stockholders will be held virtually on June 18, 2026. Stockholders will vote on the re-election of two Class III directors, Nissim Mashiach and Will McEvoy, for terms ending in 2029. Significant board changes are expected, with Joseph Loscalzo and Christopher Mirabelli stepping down, and James Cavanaugh and Richard Schilsky intending to resign, reducing the board from twelve to eight active directors. Additionally, proposals include an advisory vote on executive compensation and the ratification of EisnerAmper LLP as independent auditors for 2026.

Cypherpunk Technologies Inc. announced that four members of its Board of Directors, Dr. Christopher Mirabelli, Dr. Joseph Loscalzo, Dr. Richard Schilsky, and Dr. James Cavanaugh, will retire. Their retirements are effective immediately prior to the company's 2026 Annual Meeting of Stockholders. The company stated that these departures are not due to any disagreements with the company's operations, policies, or practices.